CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $950,019
- in 1 filing
Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-25 | MOATAZEDI DAVID See Remarks | Grant or award | +187,927 | 679,888 | ||
| 2023-01-25 | MOATAZEDI DAVID See Remarks | Grant or award · Stock Option (Right to Buy) | +257,009 | 257,009 | ||
| 2023-01-25 | Beaver Sandra Chief Financial Officer | Grant or award | +62,642 | 99,085 | ||
| 2023-01-25 | Beaver Sandra Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +85,670 | 85,670 | ||
| 2023-01-20 | Medytox Inc. 10% owner | Sale | −37,043 | $11.04 | $409K | 7,259,500 |
| 2022-10-06 | Medytox Inc. 10% owner | Sale | −38,304 | $8.99 | $344K | 7,259,500 |
| 2022-10-05 | Medytox Inc. 10% owner | Sale | −6,848 | $8.95 | $61K | 7,297,804 |
| 2022-09-15 | Medytox Inc. 10% owner | Sale | −24,000 | $10.34 | $248K | 7,304,652 |
| 2022-09-14 | Medytox Inc. 10% owner | Sale | −73,000 | $10.27 | $750K | 7,328,652 |
| 2022-09-12 | HAYMAN ROBERT Director | Purchase | +1,091 | $10.78 | $12K | 10,000 |
| 2022-09-09 | HAYMAN ROBERT Director | Purchase | +8,909 | $10.35 | $92K | 8,909 |
| 2022-09-09 | Medytox Inc. 10% owner | Sale | −20,700 | $10.53 | $218K | 7,401,652 |
| 2022-09-08 | Medytox Inc. 10% owner | Sale | −15,300 | $10.39 | $159K | 7,422,352 |
| 2022-09-07 | HAYMAN ROBERT Director | Purchase | +5,000 | $10.05 | $50K | 39,881 |
| 2022-09-07 | HAYMAN ROBERT Director | Purchase | +4,967 | $10.05 | $50K | 39,848 |
| 2022-09-06 | BLANK SIMONE Director | Purchase | +20,000 | $9.24 | $185K | 54,881 |
| 2022-09-06 | FARRELL PETER C Director | Purchase | +10,000 | $9.10 | $91K | 10,000 |
| 2022-09-05 | Beaver Sandra Chief Financial Officer | Grant or award | +36,443 | 36,443 | ||
| 2022-09-05 | Beaver Sandra Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +169,158 | 169,158 | ||
| 2022-08-01 | Medytox Inc. 10% owner | Sale | −26,000 | $13.28 | $345K | 7,437,652 |
Page 9 of 16 · 303 trades